You are Trying to View a Free Article
Daily News You Can't Find Anywhere ElseCOVID-19 Impacts Pharmaceutical & Biotech Industry in South America, an Industrial Info Market Brief
Industry Segment: Market Brief | Word Count: 103 Words
South America's Pharmaceutical & Biotech Industry has begun to feel the impact of COVID-19, and most companies are postponing maintenance and capital projects, and only focusing on operating plants with essential staff.
For instance, Brazilian company Geolab stopped construction on a project in Anapolis, Goias, where the project's completion may take at least four more months. The same situation is happening with a grassroot project in Chorrillos, Peru, where Laboratorios Induquimica has re-scheduled authorization for expenditure within six months. In Argentina, Sinergium Biotech may not review the authorization for expenditure for its line addition project in Garin, Buenos Aires, until July.
Subscribe Now! All Fields Required...
Related Articles
- Russia Plans $14.17 Billion on Ethylene Projects to Kick Off in 2021, an In...
- Japan's JFE Steel, NEDO Begin Demonstration Testing of Ferro Coke Productio...
- Refineria di Korsou to Pick Operator for Netherlands Antilles Refinery in 2...
- BPCL Bottom Upgradation Project on Hold in India due to Privatization Plans...
- Iran's Chemical Industry Plans $180 Million in Maintenance Work for 2021, a...
- Current Economic Indicators
- Free Daily Industrial Articles
- Monthly Industrial Newsletter
- IIR's Disaster Impact Tracker